DE69805473D1 - Arylsulfonylaminohydroxamsäurederivate - Google Patents

Arylsulfonylaminohydroxamsäurederivate

Info

Publication number
DE69805473D1
DE69805473D1 DE69805473T DE69805473T DE69805473D1 DE 69805473 D1 DE69805473 D1 DE 69805473D1 DE 69805473 T DE69805473 T DE 69805473T DE 69805473 T DE69805473 T DE 69805473T DE 69805473 D1 DE69805473 D1 DE 69805473D1
Authority
DE
Germany
Prior art keywords
aryl
angiogenisis
occular
scleritis
sepsis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69805473T
Other languages
English (en)
Other versions
DE69805473T2 (de
Inventor
Ralph Pelton Robinson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Products Inc
Original Assignee
Pfizer Products Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Products Inc filed Critical Pfizer Products Inc
Application granted granted Critical
Publication of DE69805473D1 publication Critical patent/DE69805473D1/de
Publication of DE69805473T2 publication Critical patent/DE69805473T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C311/16—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
    • C07C311/19—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom to an acyclic carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
DE69805473T 1997-08-08 1998-07-27 Arylsulfonylaminohydroxamsäurederivate Expired - Fee Related DE69805473T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5520897P 1997-08-08 1997-08-08

Publications (2)

Publication Number Publication Date
DE69805473D1 true DE69805473D1 (de) 2002-06-27
DE69805473T2 DE69805473T2 (de) 2003-01-16

Family

ID=21996365

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69805473T Expired - Fee Related DE69805473T2 (de) 1997-08-08 1998-07-27 Arylsulfonylaminohydroxamsäurederivate

Country Status (9)

Country Link
EP (1) EP0895988B1 (de)
JP (1) JPH11116549A (de)
AT (1) ATE217863T1 (de)
BR (1) BR9803128A (de)
CA (1) CA2244501C (de)
DE (1) DE69805473T2 (de)
DK (1) DK0895988T3 (de)
ES (1) ES2176913T3 (de)
PT (1) PT895988E (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PA8469601A1 (es) 1998-04-10 2000-09-29 Pfizer Prod Inc Procedimiento para alquilar sulfonamidas impedidas estericamente
GT199900044A (es) * 1998-04-10 2000-09-14 Procedimientos para preparar haluros de fenoxifenilsulfonilo.
PA8469301A1 (es) 1998-04-10 2000-09-29 Pfizer Prod Inc Procedimientos para la preparacion de acidos hidroxamicos.
AU3196300A (en) * 1999-03-26 2000-10-16 Shionogi & Co., Ltd. Carbocyclic sulfonamide derivatives
DK1041072T3 (da) * 1999-03-31 2003-11-10 Pfizer Prod Inc Dioxocyclopentylhydroxamsyrer
IL138686A0 (en) 1999-10-01 2001-10-31 Pfizer Prod Inc α- SULFONYLAMINO HYDROXAMIC ACID INHIBITORS OF MATRIX METALLOPROTEINASES FOR THE TREATMENT OF PERIPHERAL OR CENTRAL NERVOUS SYSTEM DISORDERS
US6808902B1 (en) 1999-11-12 2004-10-26 Amgen Inc. Process for correction of a disulfide misfold in IL-1Ra Fc fusion molecules
US7141607B1 (en) 2000-03-10 2006-11-28 Insite Vision Incorporated Methods and compositions for treating and inhibiting retinal neovascularization
JP2003528082A (ja) 2000-03-21 2003-09-24 ザ プロクター アンド ギャンブル カンパニー ニフッ化酪酸メタロプロテアーゼ阻害物質
HUP0300235A2 (hu) 2000-03-21 2003-08-28 The Procter & Gamble Co. Heterociklikus oldalláncot tartalmazó, N-szubsztituált metalloproteáz inhibitorok, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
CN1366524A (zh) * 2000-04-07 2002-08-28 三星电子株式会社 磺胺衍生物作为基质金属蛋白酶抑制剂
ES2345977T3 (es) * 2001-03-14 2010-10-07 Novartis Ag Derivados de acido acetico azacicloalquil sustituidos para uso como inhibidores de mmp.
SG173211A1 (en) 2001-06-26 2011-08-29 Amgen Inc Antibodies to opgl
US7176217B2 (en) 2001-11-13 2007-02-13 Shiseido Co., Ltd. Azabicyclo compound matrix metalloprotease inhibitor and skin preparation
PE20030701A1 (es) 2001-12-20 2003-08-21 Schering Corp Compuestos para el tratamiento de trastornos inflamatorios
WO2003055851A1 (fr) 2001-12-27 2003-07-10 Sumitomo Pharmaceuticals Company, Limited Derives d'acide hydroxamique et inhibiteur des mmp contenant ces derniers en tant que substance active
EP1578782A4 (de) 2002-12-30 2007-09-12 Amgen Inc Kombinationstherapie mit costimulierenden faktoren
GB0326546D0 (en) * 2003-11-14 2003-12-17 Amersham Plc Inhibitor imaging agents
ZA200605247B (en) * 2003-12-15 2007-10-31 Japan Tobacco Inc N-substituted-n-sulfonylaminocyclopropane compounds and pharmaceutical use thereof
AU2004299455A1 (en) 2003-12-15 2005-06-30 Japan Tobacco Inc. Cyclopropane compounds and pharmaceutical use thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2303850B (en) * 1994-06-22 1998-06-10 British Biotech Pharm Metalloproteinase inhibitors
US5863949A (en) * 1995-03-08 1999-01-26 Pfizer Inc Arylsulfonylamino hydroxamic acid derivatives
CA2264284A1 (en) * 1996-08-23 1998-02-26 Ralph P. Robinson Arylsulfonylamino hydroxamic acid derivatives

Also Published As

Publication number Publication date
BR9803128A (pt) 2000-05-02
EP0895988B1 (de) 2002-05-22
ATE217863T1 (de) 2002-06-15
DE69805473T2 (de) 2003-01-16
CA2244501A1 (en) 1999-02-08
ES2176913T3 (es) 2002-12-01
JPH11116549A (ja) 1999-04-27
DK0895988T3 (da) 2002-09-09
CA2244501C (en) 2003-03-18
EP0895988A1 (de) 1999-02-10
PT895988E (pt) 2002-09-30

Similar Documents

Publication Publication Date Title
DE69805473D1 (de) Arylsulfonylaminohydroxamsäurederivate
EP0818442A3 (de) Cyclische Sulphonderivate als Metalloproteinase-Inhibitoren und zur Hemmung der Produktion von Tumornekrosefaktor
MY113586A (en) Aylsulfonylamino hydroxamic acid derivatives
CA2218503A1 (en) Arylsulfonyl hydroxamic acid derivatives
FR2744010B1 (fr) Procede de fabrication d'implants osseux
CA2349227A1 (en) Substituted 2-phenylbenzimidazoles, the production thereof and their use
AP9801174A0 (en) Cyclic sulfone derivatives.
WO2004024081A3 (en) Acetyl 2-hydroxy-1,3 diaminoalkanes
ZA987087B (en) Chemical compounds
YU37499A (sh) Derivati arilsulfonil hidroksamske kiseline
FR2735351B1 (fr) Implant pour le traitement chirurgical d'une fracture isthmique vertebrale
DK0738107T3 (da) Inhibitorer for fedtsyresyntese som antimikrobielle midler
CA2260898A1 (en) Phosphinate based inhibitors of matrix metalloproteases
CA2185984A1 (en) Medicament for the alleviation or treatment of symptom derived from ischemic disease and compound useful therefor
WO2003007719A1 (en) Cleansers, cleansing system, bleaching agents and compositions for enviromental conservation
PT1049703E (pt) Aldeido do acido n-¬2-(5-benziloxicarbonilamino-6-oxo-2-(4-fluorofenil)-1,6-di-hidro-1-pirimidinil)acetoxil|-l-aspartico como inibidor da enzima de conversao da interleucina-1beta in vivo
BR9911010A (pt) Inibidores de sucinamida de enzima de conversão da interleucina-1beta
NO20010490L (no) Inhibisjon av ''graft-versus-host''-sykdom
PT900211E (pt) Tiadiazolil(tio)ureias uteis como inibidores de metaloproteases com matriz
TNSN05067A1 (en) Acetyl 2-hydroxy- 1,3 diaminoalkanes
FR2775919B1 (fr) Procede de traitement "mecano-chimique" d'un materiau
WO2000015208A3 (en) New use of immunosupressants for mmp-mediated diseases
TNSN04055A1 (fr) Formes cristallines anhydres de gabapentine
IT1291511B1 (it) Estensore di catena per la sintesi di polimeri biocompatibili eparinizzabili
TR200003877T2 (tr) İnsan CD23 üretiminin ve TNF salınmasının ihhibitörleri olan hiydroxamic acid türevleri

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee